Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine

Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine

Cystic fibrosis (CF) is a monogenic autosomal recessive disease caused by cystic fibrosis transmembrane conductance regulator (<i>CFTR</i>) gene mutations. CF is characterized by a high phenotypic variability present even in patients with the same genotype. This is due to the interventio...

Full description

Bibliographic Details
Main Authors:	Lăcrămioara Ionela Butnariu, Elena Țarcă, Elena Cojocaru, Cristina Rusu, Ștefana Maria Moisă, Maria-Magdalena Leon Constantin, Eusebiu Vlad Gorduza, Laura Mihaela Trandafir
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Journal of Clinical Medicine
Subjects:	cystic fibrosis CFTR modifier genes phenotypic variability GWAS
Online Access:	https://www.mdpi.com/2077-0383/10/24/5821

Similar Items

Genotype-phenotype correlation in cystic fibrosis patients bearing [H939R;H949L] allele
by: Angela Polizzi, et al.
Published: (2011-01-01)

Can Bioactive Food Substances Contribute to Cystic Fibrosis-Related Cardiovascular Disease Prevention?
by: Laura Mihaela Trandafir, et al.
Published: (2023-01-01)

New Therapies to Correct the Cystic Fibrosis Basic Defect
by: Christelle Bergeron, et al.
Published: (2021-06-01)

Functional Consequences of CFTR Interactions in Cystic Fibrosis
by: Yashaswini Ramananda, et al.
Published: (2024-03-01)

Lung Microbiome in Cystic Fibrosis
by: Filippo Scialo, et al.
Published: (2021-01-01)

Long-Term Pulmonal Therapy of Cystic Fibrosis-Patients with Amitriptyline
by: Constantin Adams, et al.
Published: (2016-07-01)

Analysis of the genotypic profile and its relationship with the clinical manifestations in people with cystic fibrosis: study from a rare disease registry
by: Senay Rueda-Nieto, et al.
Published: (2022-06-01)

Bicarbonate Transport in Cystic Fibrosis and Pancreatitis
by: Dora Angyal, et al.
Published: (2021-12-01)

Pregnancy in Cystic Fibrosis—Past, Present, and Future
by: Michal Gur, et al.
Published: (2023-02-01)

'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations
by: Knowles Michael R, et al.
Published: (2001-08-01)

The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes
by: Sana Hasan, et al.
Published: (2022-09-01)

Cystic fibrosis: current concepts
by: Jaime A. López-Valdez, et al.
Published: (2021-01-01)

Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome
by: Lăcramioara Ionela Butnariu, et al.
Published: (2023-07-01)

NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis
by: Chiara Brandas, et al.
Published: (2021-09-01)

Pancreatitis in A Patient with Cystic Fibrosis Taking Ivacaftor
by: Argyri Petrocheilou, et al.
Published: (2020-01-01)

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
by: Iwona Pranke, et al.
Published: (2019-02-01)

A retrospective study of cases diagnosed with cystic fibrosis at a single care center in Syria
by: Raghad Al-Baba, et al.
Published: (2021-06-01)

The Genetic Architecture of the Etiology of Lower Extremity Peripheral Artery Disease: Current Knowledge and Future Challenges in the Era of Genomic Medicine
by: Lăcrămioara Ionela Butnariu, et al.
Published: (2022-09-01)

Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier Genes
by: Julie Mésinèle, et al.
Published: (2022-11-01)

Cystic Fibrosis - a very common genetic disease among the population - a general review
by: Julia Rutkowska, et al.
Published: (2023-06-01)

Clinical expression of cystic fibrosis in a large cohort of Italian siblings
by: Vito Terlizzi, et al.
Published: (2018-12-01)

Efficacy and Safety of Elexacaftor-Tezacaftor-Ivacaftor in the Treatment of Cystic Fibrosis: A Systematic Review
by: Nikoletta Kapouni, et al.
Published: (2023-03-01)

Activity of lumacaftor is not conserved in zebrafish Cftr bearing the major cystic fibrosis‐causing mutation
by: Onofrio Laselva, et al.
Published: (2019-10-01)

Obesity in cystic fibrosis
by: Katherine A. Kutney, et al.
Published: (2021-12-01)

The true panel of cystic fibrosis mutations in the Sicilian population
by: Sandrine Chamayou, et al.
Published: (2020-05-01)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
by: Caitlyn Harvey, et al.
Published: (2022-03-01)

Atypical cystic fibrosis diagnosed in a14-year-old boy
by: Iwona Stelmach, et al.
Published: (2016-06-01)

Molecular and Functional Basis of Cystic Fibrosis in Indian Patients: Genetic, Diagnostic and Therapeutic Implications
by: Rajendra Prasad
Published: (2018-10-01)

Nutritional Status and Circulating Levels of Fat-Soluble Vitamins in Cystic Fibrosis Patients: A Cohort Study and Evaluation of the Effect of CFTR Modulators
by: Michela Francalanci, et al.
Published: (2023-01-01)

Profile of tezacaftor/ivacaftor combination and its potential in the treatment of cystic fibrosis
by: Shiferaw D, et al.
Published: (2019-08-01)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
by: Kiera H. Harwood, et al.
Published: (2021-07-01)

Cystic Fibrosis, CFTR, and Colorectal Cancer
by: Patricia Scott, et al.
Published: (2020-04-01)

High-Dose Ibuprofen in Cystic Fibrosis
by: Larry C. Lands, et al.
Published: (2010-07-01)

Impact of <i>CFTR</i> Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease
by: Aniello Meoli, et al.
Published: (2022-10-01)

Fibrosis Quística: mutaciones más frecuentes en la población mundial Cystic fibrosis: more frequent mutations in world population
by: Teresa Collazo Mesa
Published: (2008-06-01)

Clinical and Genetic Characterisation of Cystic Fibrosis Patients in Latvia: A Twenty-Five-Year Experience
by: Madara Auzenbaha, et al.
Published: (2022-11-01)

Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies
by: Annalucia Carbone, et al.
Published: (2023-10-01)

Elexacaftor/Tezacaftor/Ivacaftor Accelerates Wound Repair in Cystic Fibrosis Airway Epithelium
by: Onofrio Laselva, et al.
Published: (2022-09-01)

Corneal Refractive Surgery Considerations in Patients with Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders
by: Moshirfar M, et al.
Published: (2022-11-01)

Targeted sequencing reveals complex, phenotype-correlated genotypes in cystic fibrosis
by: Maxim Ivanov, et al.
Published: (2018-02-01)